Sei Investments CO Adaptimmune Therapeutics PLC Transaction History

Sei Investments CO

  • $74.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$1.06 - $2.16 $41,674 - $84,922
-39,316 Reduced 45.33%
47,409 $51,000
Q4 2022

Feb 10, 2023
BUY
$1.05 - $2.53 $58,209 - $140,258
55,438 Added 177.19%
86,725 $126,000
Q3 2022

Nov 14, 2022
BUY
$1.06 - $2.41 $33,164 - $75,401
31,287 New
31,287 $34,000

Others Institutions Holding ADAP

# of Institutions
83
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $105M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email